Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
Bioventus , a global leader in orthobiologic solutions, today announced the appointment of Andrew McCartney as Managing Director, International for Europe, Middle East and Africa (EMEA). McCartney, who will be responsible for leading the company’s EMEA business and growing the Bioventus Active Healing Therapies portfolio within the region, will also have responsibility for the international headquarters office in Hoofddorp, The Netherlands.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161107005127/en/
“We are very pleased Andrew is joining us to lead our growing business in EMEA,” said Tony Bihl, CEO of Bioventus. “His broad and deep experience of the European healthcare market, business management and marketing will help us accelerate our growth in key international markets.”
McCartney joins Bioventus from Stryker, where for the past 10 years he progressively grew through leadership roles in Sales, Marketing and Business Unit Management positions. He most recently served as Vice President and General Manager of the Surgical Division of Stryker Europe and previously was General Manager, MedSurg, Stryker UK & Ireland. He began his nearly 20-year career in the medical device industry with UK based distributors gaining experience in multiple segments including wound care, patient monitoring and diagnostic cardiology in both primary and acute healthcare settings.
McCartney has a Bachelor of Accountancy from the University of Glasgow.
Bioventus is an orthobiologics company that delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a global leader in active orthopaedic healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide.
Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Thomas Hill, 919-474-6715
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
WA-BROOKS-RUNNING20.9.2017 06:03 | pressemeddelelse
Brooks Levitate with DNA AMP Delivers Infinite Energy
IPSEN19.9.2017 18:03 | pressemeddelelse
Ipsen Receives Approval from European Commission for Xermelo® (Telotristat Ethyl) for the Treatment of Carcinoid Syndrome Diarrhea in Patients Inadequately Controlled by Somatostatin Analogue Therapy
CA-PATIENT-SAFETY-MVMNT19.9.2017 17:02 | pressemeddelelse
6th Annual World Patient Safety, Science & Technology Summit to Be Held in London, England
MA-VERTEX19.9.2017 16:52 | pressemeddelelse
Vertex Announces Upcoming Presentations of Data at 2017 North American Cystic Fibrosis Conference
DELTICOM-AG19.9.2017 15:59 | pressemeddelelse
Biker Summer 2017 campaign: Last Chance to Win Great Prizes from Moto-tyres.co.uk
CA-ANDERSEN-TAX19.9.2017 15:32 | pressemeddelelse
Andersen Global Expands into Uruguay
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum